
We’re reader-supported and may be paid when you visit links to partner sites. We don’t compare all products in the market, but we’re working on it!
Control Bionics is a medical devices business based in Australia. Control Bionics shares (CBL) are listed on the Australian Securities Exchange (ASX) and all prices are in Australian dollars. Control Bionics has a trailing 12-month revenue of around $4.2 million. If you're looking to buy shares, check out the steps below.
How to buy shares in Control Bionics
- Compare share trading platforms. To buy shares listed in Australia, you'll need to sign up to a broker with access to the ASX. Our table can help you choose.
- Open and fund your brokerage account. Complete an application with your personal and financial details, such as your ID and tax file number. Fund your account with a bank transfer, PayPal or debit card.
- Search for Control Bionics. Find the share by name or ticker symbol: CBL. Research its history to confirm it's a solid investment against your financial goals.
- Purchase now or later. Buy today with a market order or use a limit order to delay your purchase until Control Bionics reaches your desired price. Look into dollar-cost averaging to spread out your risk, which smooths out buying at consistent intervals and amounts.
- Decide on how many to buy. At today's price, weigh your budget against a diversified portfolio that can minimise risk through the market's ups and downs.
- Check on your investment. Congratulations, you own a part of Control Bionics. Optimise your portfolio by tracking how your stock and the business performs with an eye on the long term. You may be eligible for dividends and shareholder voting rights on directors and management that affect your stock.
Our top pick for
US stocks

Our top pick for
Overall broker

Our top pick for
Low-cost broker

Control Bionics stock price (ASX:CBL)
Use our graph to track the performance of CBL stocks over time.Control Bionics shares at a glance
52-week range | $0.115 - $0.745 |
---|---|
50-day moving average | $0.2558 |
200-day moving average | $0.4075 |
Target price | $1.32 |
PE ratio | N/A |
Dividend yield | $0 (0%) |
Earnings per share (TTM) | $-0.067 |
Compare share trading platforms
Is it a good time to buy Control Bionics stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. However, this is not a recommendation. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
Control Bionics price performance over time
Historical closes compared with the last close of A$0.2
1 week (2022-06-24) | 42.86% |
---|---|
1 month (2022-06-02) | -18.37% |
3 months (2022-04-01) | -41.18% |
6 months (2021-12-31) | -52.94% |
1 year (2021-07-02) | -70.15% |
---|
Control Bionics financials
Revenue TTM | $4.2 million |
---|---|
Gross profit TTM | $2.7 million |
Return on assets TTM | -15.94% |
Return on equity TTM | -31.03% |
Profit margin | -133.49% |
Book value | 0.171 |
Market capitalisation | $13 million |
TTM: trailing 12 months
Control Bionics share dividends
We're not expecting Control Bionics to pay a dividend over the next 12 months.
Control Bionics overview
Control Bionics Limited engages in the research, development, commercialization, and sale of assistive communications technology systems that allows user with speech and movement disabilities in Australia and North America. It offers NeuroNode Trilogy, a wearable device solution for those living with paralysis and loss of speech; NeuroNode3, a wearable EMG control device; and Control Bionics CCS that allow users to communicate with friends and family, send and receive emails and text messages, browse the web, watch videos and movies, read the news, play games, control their home environmental control systems, and others. The company was formerly known as Control Bionics Holdings Pty Limited and changed its name to Control Bionics Limited in September 2020. Control Bionics Limited was incorporated in 2005 and is based in Camberwell, Australia.
Stocks similar to Control Bionics
Control Bionics in the news
Frequently asked questions
More guides on Finder
-
How to buy Kincora Copper (KCC) shares
Steps to owning and managing Kincora Copper shares.
-
How to invest in the Dragon Mountain Gold IPO
Everything we know about the Dragon Mountain Gold IPO, plus information on how to buy in.
-
How to buy Arcadia Minerals (AM7) shares
Steps to owning and managing Arcadia Minerals shares.
-
How to buy Nexgen Energy (NXG) shares
Steps to owning and managing Nexgen Energy shares.
-
How to buy Keypath Education (KED) shares
Steps to owning and managing Keypath Education shares.
-
What are green bonds and how do they impact the world?
If you want to directly fund climate solutions a green bond is a great place to start. Here is how they work.
-
5 best ways to invest money in Australia in 2022
What's the best way to invest money in Australia? Find out about robo advisors, index funds, cryptocurrency and more in this guide.
-
How to buy EBR Systems (EBR) shares
Steps to owning and managing EBR Systems shares.
-
How to buy 5E Advanced Materials (5EA) shares
Steps to owning and managing 5E Advanced Materials shares.
-
How to buy Leo lithium (LLL) shares
Steps to owning and managing Leo lithium shares.
Ask an Expert